3 withdrawn, 2 completed, 2 terminated, 1 recruiting. 8 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Withdrawn 3, Completed 2, Terminated 2, Recruiting 1 |
| Phase 1 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
Follow Persistent Fetal Circulation Syndrome: new trials by email Literature Review of Persistent Fetal Circulation Syndrome trials Research Report on Persistent Fetal Circulation Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn Magnesium sulfate, Sildenafil Citrate, Isotonic saline - Persistent Pulmonary Hypertension of Newborn | Phase 1 / Phase 2 | Recruiting | Sohag University | 40 | 2021-06-02 | 2024-11-27 |
| Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn Nebulized Magnesium Sulfate, Intravenous Magnesium Sulfate - Persistent Fetal Circulation, Persistent Pulmonary Hypertension of the Newborn | Phase 1 / Phase 2 | Completed | Sohag University | 28 | 2017-11-01 | 2020-08-18 |
| Milrinone in Congenital Diaphragmatic Hernia Milrinone, Placebo (5% Dextrose) - Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn | Phase 2 | Completed | NICHD Neonatal Research Network | 66 | 2017-10-24 | 2025-11-06 |
| Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn IV Remodulin, Placebo - Persistent Pulmonary Hypertension of the Newborn | Phase 2 | Terminated | United Therapeutics | 42 | 2015-07-29 | 2024-03-05 |
| IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn Sildenafil - Persistent Pulmonary Hypertension of the Newborn | Phase 2 | Withdrawn | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-03-01 | 2021-02-02 | |
| Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) sildanefil - PPHN, Persistent Pulmonary Hypertension of the Newborn | Phase 2 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 4 | 2010-12-01 | 2021-02-01 |
| Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients Iloprost, Placebo - Pulmonary Hypertension, Neonatal Hypoxic Respiratory Failure | Phase 1 / Phase 2 | Withdrawn | Seattle Children's Hospital | 2009-09-01 | 2015-01-19 | |
| Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure Inhaled Prostaglandin E1 - Infant, Newborn, Respiratory Insufficiency | Phase 2 | Withdrawn | NICHD Neonatal Research Network | 2008-05-01 | 2019-03-22 |
Hypertension, Pulmonary (2) · Hypoxia (2) · Respiratory Insufficiency (2) · Heart Defects, Congenital (1) · Hernias, Diaphragmatic, Congenital (1) · Meconium Aspiration Syndrome (1) · Respiratory Distress Syndrome (1) · Respiratory Distress Syndrome, Newborn (1) · Streptococcal Infections (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Infant, Newborn, Diseases (8) · Lung Diseases (8) · Respiratory Tract Diseases (8) · Hypertension, Pulmonary (6) · Pathological Conditions, Signs and Symptoms (3) · Respiration Disorders (3) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Hypertension (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Vascular Diseases (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1)
Sildenafil Citrate (2) · Alprostadil (1) · Glucose (1) · Iloprost (1) · Magnesium Sulfate (1) · Milrinone (1) · Saline Solution (1) · Sodium Chloride (1) · treprostinil (1)
NICHD Neonatal Research Network (2) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2) · Sohag University (2) · Seattle Children's Hospital (1) · United Therapeutics (1)
United States (3) · Egypt (2) · United Kingdom (1)
Elsayed Abdelkreem, MD, PhD (2) · Delphine Yung, MD (1) · Edward F. Bell, MD (1) · Krisa P. Van Meurs, MD (1) · Kristi L. Watterberg, MD (1) · Michele C. Walsh, MD MS (1) · Pablo J. Sanchez, MD (1) · Roger G. Faix, MD (1) · Ronald N. Goldberg, MD (1) · Satyan Lakshminrusimha, M.D. (1) · Seetha Shankaran, MD (1) · Waldemar A. Carlo, MD (1)
PMID 25496504, PMID 29209510, PMID 33415555
U10HD036790 (2), U10HD021364 (1), U10HD021385 (1), U10HD027880 (1), U10HD034216 (1), U10HD040492 (1), U10HD040689 (1), U10HD053089 (1), U10HD053109 (1), U10HD053119 (1), U10HD053124 (1), UG1HD021364 (1), UG1HD027851 (1), UG1HD027853 (1), UG1HD027880 (1)